Speaker illustration

Associate Professor Marija Polovina

Institute for Cardiovascular Diseases, Clinical Center of Serbia, Belgrade (Serbia)

Member of:

European Society of Cardiology
Heart Failure Association

CURRENT POSITION - Assistant Professor, Internal Medicine and Cardiology, Faculty of Medicine, Belgrade University - MD, Specialist in internal medicine and cardiology, Department of Cardiology, Clinical Centre of Serbia - FESC, FHFA SPECIAL AREA OF INTEREST AND EXPERTISE - HF epidemiology, cardiomyopathies, epidemiology, clinical management - Metabolic syndrome, T2DM - Atrial fibrillation - Cardiac rhythm disorders and congenital arrhythmogenic syndromes PROFESSIONAL ACTIVITIES - MD, Specialist in Internal Medicine and Cardiology, Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia - Ass. Professor Int. Medicine and Cardiology, Faculty of Medicine, Belgrade University - National Coordinator, European Society of Cardiology, Heart Failure Association, Heart Failure Phase III Registry - Member, HFA Committee on Surveys, Registries 2018-2020

Worsening heart failure in the elderly - How I did treat.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Treatment

Session: How Should I Treat My Elderly Patient with Worsening Heart Failure?

Thumbnail

Worsening heart failure in the elderly - Case presentation.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Treatment

Session: How Should I Treat My Elderly Patient with Worsening Heart Failure?

Thumbnail

Impact of type 2 diabetes on incidence and phenotype of heart failure in patients with atrial fibrillation

Event: ESC CONGRESS 2019

Topic: Comorbidities

Session: Heart failure and diabetes: what is on the horizon

Thumbnail

Chronic heart failure confers a higher risk of non-cardiovascular death in a patients with atrial fibrillation

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Comorbidities

Session: Chronic Heart Failure - Clinical

Thumbnail

A case of a patient with heart failure, atrial fibrillation and wide QRS – indication for a CRT-D?

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Chronic Heart Failure, Other

Session: HFA Focus

Thumbnail

Diabetes increases long-term risk of new-onset heart failure and mortality in atrial fibrillation: impact of glycaemic control and diabetes treatment

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Comorbidities

Session: Chronic Heart Failure - Clinical

Thumbnail

Association between type-2 diabetes and 5-year heart failure outcomes in patients with atrial fibrillation

Event: ESC Congress 2018

Topic: Comorbidities

Session: Chronic heart failure - Clinical

Thumbnail

Statins and the risk of major adverse cardiac events in patients with atrial fibrillation without coronary artery disease: a propensity score adjusted analysis

Event: EHRA 2018

Topic: Atrial Fibrillation - Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation - Clinical

Thumbnail

Association of the metabolic syndrome with 5-year major adverse cardiac events in patients with atrial fibrillation: a propensity-score adjusted analysis

Event: EHRA 2018

Topic: Atrial Fibrillation - Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation - Clinical

Thumbnail

The 2MACE score predicts major adverse cardiovascular outcomes in patients with atrial fibrillation without overt coronary artery disease

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Clinical and epidemiological aspects (Atrial Fibrillation)

Session: Rapid Fire session 8 - Atrial fibrillation and stroke prevention

Thumbnail

This platform is supported by

logo Novo Nordisk